At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 42 enrolled
Drug / intervention
Furosemide +1 moredrug
Likely dose
Furosemide 0.1mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Utilization of Furosemide to Expedite Bladder Filling in Pediatric Females With Suspected Ovarian Torsion Awaiting Pelvic Ultrasound
In Brief
A Early Phase 1 clinical trial evaluating Furosemide and Normal saline for Ovarian Torsion. Completed, enrolled 42 participants across 1 site.
Detailed Summary
The purpose of this study is to investigate whether or not furosemide causes the bladder to fill faster than IV fluids alone so that a pelvic ultrasound exam can be performed.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOvarian Torsion
CountriesUnited States
Collaborators--
Timeline
Early Ph 1CompletedFinished
20222023202420252026
Enrollment StartMay 2021
First PostedOct 2021
Primary CompletionDec 2023
TodayJul 2026
First PostedOct 28, 2021
Enrollment StartMay 29, 2021
Primary CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 4.7 years ago
Interventions
Furosemidedrug
0.1mg/kg (max 5mg) of IV furosemide
Normal salinedrug
20mL/kg (max 1000mL) normal saline bolus plus a normal saline flush